1
|
Kaplan MA, Şendur MAN, Cangır AK, Fırat P, Göker E, Kılıçkap S, Oyan B, Büge Öz A, Özdemir F, Özyiğit G. Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group. Curr Probl Cancer 2023; 47:101017. [PMID: 37845104 DOI: 10.1016/j.currproblcancer.2023.101017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 08/16/2023] [Accepted: 09/05/2023] [Indexed: 10/18/2023]
Abstract
Pleural mesothelioma (PM) is a cancer of the pleural surface, which is aggressive and may be rapidly fatal. PM is a rare cancer worldwide, but is a relatively common disease in Turkey. Asbestos exposure is the main risk factor and the most common underlying cause of the disease. There have been significant improvements in diagnoses and treatments of many malignancies; however, there are still therapeutic challenges in PM. In this review, we aimed to increase the awareness of health care professionals, oncologists, and pulmonologists by underlining the unmet needs of patients with PM and by emphasizing the need for a multidisciplinary treatment and management of PM. After reviewing the general information about PM, we further discuss the treatment options for patients with PM using immunotherapy and offer evidence for improvements in the clinical outcomes of these patients because of these newer treatment modalities.
Collapse
Affiliation(s)
- Muhammet Ali Kaplan
- Department of Medical Oncology, Dicle University Hospitals Faculty of Medicine, Diyarbakır, Turkey.
| | - Mehmet Ali Nahit Şendur
- Department of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey
| | - Ayten Kayı Cangır
- Department of Thoracic Surgery, Ankara University Faculty of Medicine, Ibni Sina Hospital, Ankara, Turkey
| | - Pınar Fırat
- Department of Pathology, Koc University School of Medicine, Istanbul, Turkey
| | - Erdem Göker
- Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey
| | - Saadettin Kılıçkap
- Department of Medical Oncology, Liv Hospital Ankara, Ankara, Turkey; Department of Medical Oncology, Istinye University Faculty of Medicine, Istanbul, Turkey
| | - Başak Oyan
- Department of Medical Oncology, Acıbadem University Faculty of Medicine, Istanbul, Turkey
| | - Ayşim Büge Öz
- Department of Medical Pathology, Istanbul University Cerrahpaşa Faculty of Medicine, Istanbul, Turkey
| | - Feyyaz Özdemir
- Department of Medical Oncology, Karadeniz Technical University, Trabzon, Turkey
| | - Gökhan Özyiğit
- Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
| |
Collapse
|
2
|
Bulutay P, Atasoy Ç, Erus S, Tanju S, Dilege Ş, Fırat P. Scrape cytology and radiological solid size correlation can be used in the intraoperative management of subsolid lung nodules. Diagn Cytopathol 2023; 51:239-250. [PMID: 36519435 DOI: 10.1002/dc.25089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/07/2022] [Accepted: 11/30/2022] [Indexed: 12/23/2022]
Abstract
BACKGROUND The term radiologic subsolid lung nodule (SLN) represents a heterogeneous group of non-neoplastic and neoplastic lesions. Intraoperative evaluation (IO) is often required to differentiate and diagnose. The current study aims to investigate the feasibility and reliability of scrape cytology (SC) and radiologic solid size correlation for the IO diagnosis of SLNs. METHODS Sixty-eight patients with SLN signs were eligible to take part in the study due to intraoperatively prepared SC slides. We managed to complete the blind radiologic solid size measurement and cytologic evaluation retrospectively. Cases were grouped into three categories based on their cytological features: Group-0 (Benign), Group-1 (mild atypical features), and Group-2 (severe atypical features/unequivocally carcinoma). IO diagnoses were given by combining the radiologic solid size and cytological findings. RESULTS Cytological features of Group-1 were observed in 100%, 93%, 32.5%, and 17% of the AIS, MIA, IA, and benign lesions, respectively. Cytological features of Group-2 were observed in 67.5%, and 7% of the IA and MIA, respectively. By combining cytology with radiologic solid size, 100%, 85%, 71%, and 83% of the AIS, IA, MIA, and benign lesions respectively were diagnosed correctly. Fifteen (15%) percent of the IA cases were underdiagnosed as MIA since their radiological solid sizes were less than 0.5 cm with cytological features of Group-1. Conversely, 29% of the MIA cases were overdiagnosed as IA since their radiological solid sizes were greater than 0.5 cm. CONCLUSION SLNs should be handled with caution in terms of IO management. SC and radiologic solid size correlation both provide a practical and tissue-protecting approach for the IO evaluation of SLNs, ensuring a high consistency between IO and definitive diagnosis.
Collapse
Affiliation(s)
- Pınar Bulutay
- Department of Pathology, Koç University Hospital, Istanbul, Turkey
| | - Çetin Atasoy
- Department of Radiology, Koç University Hospital, Istanbul, Turkey
| | - Suat Erus
- Department of Thoracic Surgery, Koç University Hospital, Istanbul, Turkey
| | - Serhan Tanju
- Department of Thoracic Surgery, Koç University Hospital, Istanbul, Turkey
| | - Şükrü Dilege
- Department of Thoracic Surgery, Koç University Hospital, Istanbul, Turkey
| | - Pınar Fırat
- Department of Pathology, Koç University Hospital, Istanbul, Turkey
| |
Collapse
|
3
|
Kuşoğlu A, Yangın K, Özkan SN, Sarıca S, Örnek D, Solcan N, Karaoğlu İC, Kızılel S, Bulutay P, Fırat P, Erus S, Tanju S, Dilege Ş, Öztürk E. Different Decellularization Methods in Bovine Lung Tissue Reveals Distinct Biochemical Composition, Stiffness, and Viscoelasticity in Reconstituted Hydrogels. ACS Appl Bio Mater 2023; 6:793-805. [PMID: 36728815 PMCID: PMC9945306 DOI: 10.1021/acsabm.2c00968] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Extracellular matrix (ECM)-derived hydrogels are in demand for use in lung tissue engineering to mimic the native microenvironment of cells in vitro. Decellularization of native tissues has been pursued for preserving organotypic ECM while eliminating cellular content and reconstitution into scaffolds which allows re-cellularization for modeling homeostasis, regeneration, or diseases. Achieving mechanical stability and understanding the effects of the decellularization process on mechanical parameters of the reconstituted ECM hydrogels present a challenge in the field. Stiffness and viscoelasticity are important characteristics of tissue mechanics that regulate crucial cellular processes and their in vitro representation in engineered models is a current aspiration. The effect of decellularization on viscoelastic properties of resulting ECM hydrogels has not yet been addressed. The aim of this study was to establish bovine lung tissue decellularization for the first time via pursuing four different protocols and characterization of reconstituted decellularized lung ECM hydrogels for biochemical and mechanical properties. Our data reveal that bovine lungs provide a reproducible alternative to human lungs for disease modeling with optimal retention of ECM components upon decellularization. We demonstrate that the decellularization method significantly affects ECM content, stiffness, and viscoelastic properties of resulting hydrogels. Lastly, we examined the impact of these aspects on viability, morphology, and growth of lung cancer cells, healthy bronchial epithelial cells, and patient-derived lung organoids.
Collapse
Affiliation(s)
- Alican Kuşoğlu
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - Kardelen Yangın
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - Sena N Özkan
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - Sevgi Sarıca
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - Deniz Örnek
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - Nuriye Solcan
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey
| | - İsmail C Karaoğlu
- Chemical and Biological Engineering, Koç University, Istanbul 34450, Turkey
| | - Seda Kızılel
- Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey.,Chemical and Biological Engineering, Koç University, Istanbul 34450, Turkey
| | - Pınar Bulutay
- Department of Pathology, School of Medicine, Koç University, Istanbul 34450, Turkey
| | - Pınar Fırat
- Department of Pathology, School of Medicine, Koç University, Istanbul 34450, Turkey
| | - Suat Erus
- Department of Thoracic Surgery, School of Medicine, Koç University, Istanbul 34450, Turkey
| | - Serhan Tanju
- Department of Thoracic Surgery, School of Medicine, Koç University, Istanbul 34450, Turkey
| | - Şükrü Dilege
- Department of Thoracic Surgery, School of Medicine, Koç University, Istanbul 34450, Turkey
| | - Ece Öztürk
- Engineered Cancer and Organ Models Laboratory, Koç University, Istanbul 34450, Turkey.,Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul 34450, Turkey.,Department of Medical Biology, School of Medicine, Koç University, Istanbul 34450, Turkey
| |
Collapse
|
4
|
Ozturk AB, Çağlayan B, Kapmaz M, Çalık I, Tekin S, İliaz S, Fırat P. Hypersensitivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination. Eur Ann Allergy Clin Immunol 2023; 55:41-45. [PMID: 35156356 DOI: 10.23822/eurannaci.1764-1489.247] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Summary Hypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvement of the dyspnea. She is still on treatment and on the follow up period, we plan to continue steroid treatment at least 3 months.
Collapse
Affiliation(s)
- A B Ozturk
- Division of Allergy and Immunology, Department of Pulmonary Medicine, School of Medicine, Koç University, Istanbul, Turkey
| | - B Çağlayan
- Department of Pulmonary Medicine, School of Medicine, Koç University, Istanbul, Turkey
| | - M Kapmaz
- Department of Infectious Diseases, School of Medicine, Koç University, Istanbul, Turkey
| | - I Çalık
- Department of Pulmonary Medicine, School of Medicine, Koç University, Istanbul, Turkey
| | - S Tekin
- Department of Infectious Diseases, Koc University Hospital, Istanbul, Turkey
| | - S İliaz
- Department of Pulmonary Medicine, Koç University Hospital, Istanbul, Turkey
| | - P Fırat
- Department of Pathology, Koç University, School of Medicine, Istanbul, Turkey
| |
Collapse
|
5
|
Marazioti A, Krontira AC, Behrend SJ, Giotopoulou GA, Ntaliarda G, Blanquart C, Bayram H, Iliopoulou M, Vreka M, Trassl L, Pepe MAA, Hackl CM, Klotz LV, Weiss SAI, Koch I, Lindner M, Hatz RA, Behr J, Wagner DE, Papadaki H, Antimisiaris SG, Jean D, Deshayes S, Grégoire M, Kayalar Ö, Mortazavi D, Dilege Ş, Tanju S, Erus S, Yavuz Ö, Bulutay P, Fırat P, Psallidas I, Spella M, Giopanou I, Lilis I, Lamort AS, Stathopoulos GT. KRAS signaling in malignant pleural mesothelioma. EMBO Mol Med 2021; 14:e13631. [PMID: 34898002 PMCID: PMC8819314 DOI: 10.15252/emmm.202013631] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 10/28/2021] [Accepted: 11/15/2021] [Indexed: 12/20/2022] Open
Abstract
Malignant pleural mesothelioma (MPM) arises from mesothelial cells lining the pleural cavity of asbestos‐exposed individuals and rapidly leads to death. MPM harbors loss‐of‐function mutations in BAP1, NF2, CDKN2A, and TP53, but isolated deletion of these genes alone in mice does not cause MPM and mouse models of the disease are sparse. Here, we show that a proportion of human MPM harbor point mutations, copy number alterations, and overexpression of KRAS with or without TP53 changes. These are likely pathogenic, since ectopic expression of mutant KRASG12D in the pleural mesothelium of conditional mice causes epithelioid MPM and cooperates with TP53 deletion to drive a more aggressive disease form with biphasic features and pleural effusions. Murine MPM cell lines derived from these tumors carry the initiating KRASG12D lesions, secondary Bap1 alterations, and human MPM‐like gene expression profiles. Moreover, they are transplantable and actionable by KRAS inhibition. Our results indicate that KRAS alterations alone or in accomplice with TP53 alterations likely play an important and underestimated role in a proportion of patients with MPM, which warrants further exploration.
Collapse
Affiliation(s)
- Antonia Marazioti
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Anthi C Krontira
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Sabine J Behrend
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Georgia A Giotopoulou
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece.,German Center for Lung Research (DZL), Gießen, Germany
| | - Giannoula Ntaliarda
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | | | - Hasan Bayram
- Department of Pulmonary Medicine, Koc University School of Medicine, Istanbul, Turkey.,Koc University Research Center for Translational Medicine (KUTTAM), Koc University School of Medicine, Istanbul, Turkey
| | - Marianthi Iliopoulou
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Malamati Vreka
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece.,German Center for Lung Research (DZL), Gießen, Germany
| | - Lilith Trassl
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Mario A A Pepe
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Caroline M Hackl
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Laura V Klotz
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Stefanie A I Weiss
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Ina Koch
- German Center for Lung Research (DZL), Gießen, Germany.,Center for Thoracic Surgery Munich, Ludwig-Maximilian-University (LMU) Munich and Asklepios Medical Center, Gauting, Germany
| | - Michael Lindner
- German Center for Lung Research (DZL), Gießen, Germany.,Center for Thoracic Surgery Munich, Ludwig-Maximilian-University (LMU) Munich and Asklepios Medical Center, Gauting, Germany
| | - Rudolph A Hatz
- German Center for Lung Research (DZL), Gießen, Germany.,Center for Thoracic Surgery Munich, Ludwig-Maximilian-University (LMU) Munich and Asklepios Medical Center, Gauting, Germany
| | - Juergen Behr
- German Center for Lung Research (DZL), Gießen, Germany.,Department of Medicine V, University Hospital, Ludwig-Maximilian-University (LMU) Munich, Munich, Germany
| | - Darcy E Wagner
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany.,Lung Bioengineering and Regeneration, Department of Experimental Medical Sciences, Lund Stem Cell Center, Wallenberg Molecular Medicine Center, Faculty of Medicine, Lund University, Lund, Sweden
| | - Helen Papadaki
- Department of Anatomy, Faculty of Medicine, University of Patras, Rio, Greece
| | - Sophia G Antimisiaris
- Laboratory for Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio, Greece.,Foundation for Research and Technology Hellas, Institute of Chemical Engineering, FORTH/ICE-HT, Rio, Greece
| | - Didier Jean
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Functional Genomics of Solid Tumors, Paris, France
| | | | - Marc Grégoire
- Université de Nantes, CNRS, INSERM, CRCINA, Nantes, France
| | - Özgecan Kayalar
- Koc University Research Center for Translational Medicine (KUTTAM), Koc University School of Medicine, Istanbul, Turkey
| | - Deniz Mortazavi
- Koc University Research Center for Translational Medicine (KUTTAM), Koc University School of Medicine, Istanbul, Turkey
| | - Şükrü Dilege
- Department of Thoracic Surgery, Koc University School of Medicine, Istanbul, Turkey
| | - Serhan Tanju
- Department of Thoracic Surgery, Koc University School of Medicine, Istanbul, Turkey
| | - Suat Erus
- Department of Thoracic Surgery, Koc University School of Medicine, Istanbul, Turkey
| | - Ömer Yavuz
- Department of Thoracic Surgery, Koc University School of Medicine, Istanbul, Turkey
| | - Pınar Bulutay
- Department of Pathology, Koc University School of Medicine, Istanbul, Turkey
| | - Pınar Fırat
- Department of Pathology, Koc University School of Medicine, Istanbul, Turkey
| | - Ioannis Psallidas
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Magda Spella
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Ioanna Giopanou
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Ioannis Lilis
- Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece
| | - Anne-Sophie Lamort
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,German Center for Lung Research (DZL), Gießen, Germany
| | - Georgios T Stathopoulos
- Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD), Helmholtz Center Munich-German Research Center for Environmental Health (HMGU) and Ludwig-Maximilian-University (LMU) Munich, Munich, Germany.,Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Rio, Greece.,German Center for Lung Research (DZL), Gießen, Germany
| |
Collapse
|
6
|
Korkmaz P, Kurtaran B, Özdemir Armağan Ş, Turan Özden H, Kacar F, Ateş S, Durmuş G, Bayındır Bilman F, Uygun Kızmaz Y, Hamidi AA, Özdemir B, Yıkılgan AB, Fırat P, İnan A, Okay G, Işık ME, But A, Uğurlu K, Harman R, Ergüt Sezer B, Doyuk Kartal E, Kuşçu F, Şener A, Mıstanoğlu Özatağ D, Tükenmez Tigen E, Dağlı Ö, Koçak F, Kuşoğlu H, Ertürk Şengel B, Demirel A, Naz H, Agalar C, Öztürk Engin D, Dökmetaş İ, Gürsul NC, Yılmaz Karadağ F, Çayıröz MU, Kürekçi Y, Kadanalı A, Çakar ZŞ, Savaşçı Ü, Erdem İ, Çağan Aktaş S. The factors affecting inadequate empirical antimicrobial therapy and clinical course in upper urinary tract infections of the elderly patients. mjima 2020. [DOI: 10.4274/mjima.galenos.2020.2020.5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
7
|
Kulaç İ, Aydın A, Bulutay P, Fırat P. Efficiency of Cytology Samples for PD-L1 Evaluation and Comparison with Tissue Samples. Turk Patoloji Derg 2020; 36:205-210. [PMID: 32692398 PMCID: PMC10510593 DOI: 10.5146/tjpath.2020.01494] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 06/07/2020] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVE Lung cancer is the leading cause of cancer-related death. PD-L1 blockers have become a first-line option for advanced non-small cell lung cancer (NSCLC) patients. Guidelines require the assessment of PD-L1 expression by immunohistochemistry. Although tissue samples are widely used, cytologic samples could be an alternative. In this study, we compared cytologic samples with tissue samples for PD-L1 evaluation in NSCLC cases. MATERIAL AND METHOD Koç University Hospital, Department of Pathology Laboratory Information System was scanned for all PD-L1 tests performed on NSCLC cases, either on tissue samples or cell blocks. The type of the biopsy/aspiration procedure, the tumor type, patient demographics, and the percentage of PD-L1 positive tumor cells were recorded. A total of 73 tissue samples and 49 cell blocks were found to be eligible for the study. RESULTS The PD-L1 positivity score was at least 1% in 44 of 73 samples of the tissue group and 19 of 49 samples of the cell block group. Tissue samples showed significantly higher positivity compared to the cell blocks (p=0.020). Comparing the frequency of cases with ≥50% positivity showed no statistically significant difference. A comparison of PD-L1 positivity rates of only the small biopsies and cell blocks also showed no significant difference. CONCLUSION Although they harbor a limited number of tumor cells, cell blocks prepared from cytologic samples are good alternatives for PD-L1 testing. However, large resections should be used for PD-L1 evaluation whenever possible since even 1% positivity may affect the treatment decision.
Collapse
Affiliation(s)
- İbrahim Kulaç
- Department of Pathology, Koç University School of Medicine, İstanbul, Turkey
| | - Aslı Aydın
- Department of Medical Student, Koç University School of Medicine, İstanbul, Turkey
| | - Pınar Bulutay
- Department of Pathology, Koç University School of Medicine, İstanbul, Turkey
| | - Pınar Fırat
- Department of Pathology, Koç University School of Medicine, İstanbul, Turkey
| |
Collapse
|
8
|
Benli Işık C, Ürer HN, Altundal K, Günlüoğlu MZ, Fırat P. Which Cytological Characteristics are More Valuable for Papillary Carcinoma in Thyroid Fine-needle Aspiration? Haseki 2017. [DOI: 10.4274/haseki.76486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
9
|
Saglam S, Ibis K, Saglam EK, Fırat P, Yilmazbayhan D, Toker A, Ozkan B, Hancer V, Buyukdogan M, Disci R. P2.01-087 Prognostic Significance of CA IX Overexpression in Stage III NSCLC Patients Received Neoadjuvant Treatment. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2016.11.1139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Abstract
Fine needle aspiration of thyroid has been used for years in a multidisciplinary approach, to diagnose different entities, in preventing over or under treatment of thyroid nodules. The widespread use of this methodology can be confirmed if "thyroid fine needle aspiration" is searched on PubMed, which results in over 5000 papers. In this manuscript, we aimed to focus on pitfalls in the evaluation of thyroid aspirations, covering cystic, inflammatory lesions, follicular lesions, oncocytic lesions, papillary carcinoma, and medullary carcinoma of thyroid.
Collapse
Affiliation(s)
- Şule Canberk
- Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey
| | | | | |
Collapse
|
11
|
Tuncer S, Yıldız Ekinci D, Darendeliler E, Fırat P. Küçük Hücreli Akciğer Kanserine Bağlı İris Metastazı. Turk J Ophthalmol 2014. [DOI: 10.4274/tjo.43.93063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
12
|
Tülin Kayhan F, Hakan Kaya K, Altıntas A, Fırat P, Sayin I. First successful transoral robotic resection of a laryngeal paraganglioma. J Otolaryngol Head Neck Surg 2012; 41:E54-E57. [PMID: 23700592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Affiliation(s)
- Fatma Tülin Kayhan
- Department of Otolaryngology, Bakırköy Dr. Sadi Konuk Trainingand Research Hospital
| | | | | | | | | |
Collapse
|
13
|
Abstract
Primary sebaceous carcinoma is an exceptionally rare tumor of the lacrimal gland and less than 10 cases have been so far published in the literature. Two adult patients aged 38 and 81 years, respectively, who suffered unilateral painful massive swelling of the lacrimal gland are described. The disease in the first patient initially manifested as ipsilateral parotid gland metastasis and the primary tumor could be detected 3 months later. Both tumors were rock hard and fixed on palpation, caused partial upper eyelid ptosis, displaced the globe anteromedially and impaired ocular motility. Magnetic resonance imaging studies showed mostly homogeneous, well-delineated and moderately contrast-enhancing lacrimal gland fossa tumors without bone destruction. The management consisted of incisional biopsy for the diagnosis, immediately followed by exenteration. The younger patient further underwent radical neck dissection, parotidectomy and orbital and neck radiotherapy, which provided him a 2-year disease-free survival. Histopathological examination showed poorly differentiated sebaceous carcinoma destructing completely the lacrimal gland with predominantly comedo pattern. Despite its rarity and lack of specific clinical and imaging signs, sebaceous carcinoma should be considered in rapidly evolving painful and hard lacrimal gland fossa tumors. Also noteworthy is the early propensity of this tumor to spread to regional draining lymph nodes and the parotid gland in particular.
Collapse
Affiliation(s)
- Hayyam Kiratli
- Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.
| | | | | |
Collapse
|
14
|
Oğuztüzün S, Sezgin Y, Yazıcı S, Fırat P, Ozhavzalı M, Ozen H. Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells. Urol Oncol 2009; 29:538-44. [PMID: 19926314 DOI: 10.1016/j.urolonc.2009.08.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2009] [Revised: 07/29/2009] [Accepted: 08/03/2009] [Indexed: 11/26/2022]
Abstract
OBJECTIVES This study investigates the usefulness of glutathione-S-transferases (GST) isoenzymes and p53 immunostaining as a marker of malignancy in urinary cytology, and evaluates their potential effect in increasing diagnostic accuracy in a series of urine cytologic samples. They are also correlated with cytopathology diagnosis and histopathologic diagnosis. MATERIALS AND METHODS In this study, the slides from 124 bladder carcinoma patients prepared by the cytocentrifugation method were observed. The cytomorphologic properties of these cancer cells were determined. Moreover, the immunocytochemical distributions of GST alpha (GSTA), pi (GSTP), mu (GSTM4), theta (GSTT1) isoenzymes and p53 protein were studied for the patients. RESULTS The urothelial cancer cells had small cytoplasm and rough nuclear membrane. The chromatin granules were heterogeneously distributed in each malignant cell's nucleus. There was a pleomorphism of the malignant cells' nuclei. According to immunocytopathologic observations, the urothelial cancer cells had stronger staining intensity than the benign cells had in 48% of cases for GSTA, 46% of cases for GSTP, 38% of cases for GSTM4, and 42% of cases for GSTT1. For all papillary cases, the malignant cells were stained negative, while the benign cells were positive. For 83% of patients, the malignant cells were stained positive for p53. There was a significant difference in GSTA (P = 0.006), GSTT1 (P = 0.004), GSTP (P = 0.000) and p53 (P = 0.000) expressions for benign cells whereas, a non-statistical difference in the malignant cells for GSTA, GSTT1, GSTP, GSTM4, and p53 expressions (P > 0.05). CONCLUSIONS GST isoenzymes and p53 immunostaining were not found to be markers of malignancy in urinary cytology.
Collapse
|
15
|
Vargel İ, Demirci M, Erdem S, Fırat P, Sürücü H, Tan E, Keçik A. A Comparison of Various Vascularization-Perfusion Venous Nerve Grafts with Conventional Nerve Grafts in Rats. J Reconstr Microsurg 2009; 25:425-37. [DOI: 10.1055/s-0029-1223852] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|